- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcome measures for progressive MS trials
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 12, Pages 1627-1635
Publisher
SAGE Publications
Online
2017-10-18
DOI
10.1177/1352458517729465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
- (2017) Peter Feys et al. Multiple Sclerosis Journal
- Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
- (2017) Robert W Motl et al. Multiple Sclerosis Journal
- Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
- (2017) Laura J Balcer et al. Multiple Sclerosis Journal
- Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
- (2017) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
- (2017) Peter Feys et al. Multiple Sclerosis Journal
- Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
- (2017) Robert W Motl et al. Multiple Sclerosis Journal
- Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
- (2017) Laura J Balcer et al. Multiple Sclerosis Journal
- Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
- (2017) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS – YES
- (2016) Jeremy Chataway Multiple Sclerosis Journal
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
- Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
- (2016) Patrick Vermersch et al. Multiple Sclerosis Journal
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis
- (2016) Diego Cadavid et al. Multiple Sclerosis Journal
- Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
- (2016) Luis Ruano et al. Multiple Sclerosis Journal
- Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS – YES
- (2016) Jeremy Chataway Multiple Sclerosis Journal
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
- Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
- (2016) Patrick Vermersch et al. Multiple Sclerosis Journal
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis
- (2016) Diego Cadavid et al. Multiple Sclerosis Journal
- Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
- (2016) Luis Ruano et al. Multiple Sclerosis Journal
- Defining reliable disability outcomes in multiple sclerosis
- (2015) Tomas Kalincik et al. BRAIN
- On the origin of Neurostatus
- (2015) Ludwig Kappos et al. Multiple Sclerosis and Related Disorders
- Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis
- (2014) Sandra Meyer-Moock et al. BMC Neurology
- Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial
- (2014) David M. Erlanger et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Composite end points to assess delay of disability progression by MS treatments
- (2014) J Zhang et al. Multiple Sclerosis Journal
- The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis
- (2014) Jeffrey A. Cohen et al. JAMA Neurology
- Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis
- (2013) Yvonne C Learmonth et al. BMC Neurology
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan
- (2013) Richard A Rudick et al. Multiple Sclerosis Journal
- The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis
- (2013) Yvonne C Learmonth et al. Multiple Sclerosis Journal
- Disability in multiple sclerosis: A reference for patients and clinicians
- (2013) I. Kister et al. NEUROLOGY
- How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register
- (2013) Kerina H. Jones et al. PLoS One
- Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review
- (2013) Derek G. Kyte et al. PLoS One
- Accelerometry as a measure of walking behavior in multiple sclerosis
- (2012) R. W. Motl et al. ACTA NEUROLOGICA SCANDINAVICA
- Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
- (2012) Ralph HB Benedict et al. BMC Neurology
- Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
- (2012) Jeffrey A Cohen et al. LANCET NEUROLOGY
- The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis
- (2012) Ayse Kuspinar et al. Multiple Sclerosis Journal
- Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
- (2012) D Ontaneda et al. Multiple Sclerosis Journal
- Reliability and clinical significance of mobility and balance assessments in multiple sclerosis
- (2012) Yvonne C. Learmonth et al. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis
- (2010) C M Rice et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integration of Cognitive Impairment in the Expanded Disability Status Scale of 215 Patients with Multiple Sclerosis
- (2010) Hélène Brissart et al. EUROPEAN NEUROLOGY
- Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
- (2010) SA Morrow et al. Multiple Sclerosis Journal
- Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
- (2010) Maria P Amato et al. Multiple Sclerosis Journal
- MRI and cognition in multiple sclerosis
- (2010) M. Filippi et al. NEUROLOGICAL SCIENCES
- Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity
- (2009) E M Mowry et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
- (2007) Myla D Goldman et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started